Shimadzu Releases Amyloid MS CL System for Measuring Candidate Substance Potentially Causing Alzheimer’s DiseaseSystem Requires Testing Only a Small Quantity of Blood, which Reduces Burden to Patients
Shimadzu Releases Amyloid MS CL System for Measuring Candidate Substance Potentially Causing Alzheimer’s Disease System Requires Testing Only a Small Quantity of Blood, which Reduces Burden to Patients
